急性巨核细胞白血病中致癌胎儿型SNHG29-IGF2BP1 RNA轴的谱系限制性依赖
该研究通过CRISPR干扰筛选在原发性AMKL样本中高表达的lncRNA,鉴定出SNHG29为谱系特异性依赖分子,其沉默在体外损害白血病增殖和克隆生长、在体内降低白血病负荷。SNHG29与异常表达的IGF2BP1相互作用,维持MYC和E2F驱动的增殖程序,小分子BTYNB抑制IGF2BP1-RNA相互作用在患者来源AMKL模型中诱导选择性细胞毒性。
要点
- SNHG29是AMKL谱系特异性依赖lncRNA,沉默可损害增殖和克隆生长。
- SNHG29与IGF2BP1互作维持MYC/E2F增殖程序。
- BTYNB抑制IGF2BP1-RNA互作在AMKL模型中选择性杀伤。
核心结论
- SNHG29与IGF2BP1形成发育共依赖的谱系限制性致癌回路,是AMKL可干预的治疗脆弱点。
研究设计与样本
- 针对原发性AMKL样本中高表达lncRNA进行CRISPR干扰筛选。
- 利用RNA pulldown联合蛋白质组学分析鉴定SNHG29互作蛋白。
- 在患者来源AMKL模型中评估BTYNB的药理作用。
主要发现
- SNHG29沉默在体外严重损害白血病增殖和克隆生长,在体内降低白血病负荷。
- SNHG29与在AMKL中异常表达的IGF2BP1相互作用。
- SNHG29维持IGF2BP1靶转录本表达,包括MYC和E2F驱动的增殖程序。
- BTYNB抑制IGF2BP1-RNA相互作用,在患者来源AMKL模型中诱导强效选择性细胞毒性。
关键数值与推荐
- SNHG29为原发性AMKL样本中高表达lncRNA筛选出的谱系特异性依赖分子。
- BTYNB为抑制IGF2BP1-RNA相互作用的小分子。
临床怎么用
- SNHG29-IGF2BP1 RNA轴可作为AMKL谱系限制性治疗靶点。
- IGF2BP1-RNA相互作用的小分子抑制在AMKL模型中显示选择性细胞毒性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute megakaryoblastic leukemia (AMKL) is a rare, aggressive subtype of acute myeloid leukemia with developmental origins in early childhood. To uncover long noncoding RNAs (lncRNAs) sustaining this high-risk malignancy, we conducted CRISPR interference screens targeting lncRNAs overexpressed in primary AMKL samples. This analysis identified SNHG29 as a previously unrecognized lineage-specific dependency, whose silencing profoundly impaired leukemic proliferation and clonogenic growth in vitro and reduced leukemic burden in vivo. RNA pulldown coupled with proteomic analysis revealed that SNHG29 interacts with the oncofetal RNA-binding protein IGF2BP1, which is aberrantly expressed in AMKL. SNHG29 was required to maintain expression of IGF2BP1 target transcripts, including MYC- and E2F-driven proliferative programs, thereby reinforcing fetal transcriptional programs essential for leukemic maintenance. Pharmacologic inhibition of IGF2BP1-RNA interactions with the small-molecule BTYNB induced potent and selective cytotoxicity in patient-derived AMKL models. Together, these findings uncover a developmental co-dependency between SNHG29 and IGF2BP1 that defines a lineage-restricted oncogenic circuit and an actionable therapeutic vulnerability in AMKL.
引用
- Winkler R, Griesler B, Sippl W, et al. Lineage-restricted dependency on an oncofetal SNHG29-IGF2BP1 RNA axis in acute megakaryoblastic leukemia. Leukemia. 2026. PMID: 42380666. doi:10.1038/s41375-026-03040-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。